
Artica Therapeutics
Artica is leveraging covalency as key differentiator to deliver oral “ antibody-in-a-pill ” solutions for patients suffering from immune mediated conditions
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredApr 10, 2020 (6 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- TBTjeerd Barf Founder, CEO & executive board membersource: artica-tx.com
- AIAd IJzerman foundersource: artica-tx.com
- ARArwin Ridder Founder and COOsource: artica-tx.com
Companies like Artica Therapeutics
KKhartis Therapeutics$95M Series B+ · Aug 2026
SSudo Bio$37M Series A · Sep 2022MMatchpoint Therapeutics$150M Series B+ · Oct 2026
AAlzheon$100M Series B+ · Apr 2022
BBionyra$165M Series A · Jun 2026
MMirador Therapeutics$250M Series B+ · Jan 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/artica-therapeutics (get a free API key).